Cardiovascular and Soft Tissue Repair Patches Market Size & Outlook, 2025-2033

Cardiovascular and Soft Tissue Repair Patches Market Size

The global cardiovascular and soft tissue repair patches market size was valued at USD 4.84 billion in 2024 and is expected to grow from USD 5.25 billion in 2025 to reach USD 10 billion in 2033, growing at a CAGR of 8.4% during the forecast period (2025–2033).

In restoration operations, cardiovascular and soft tissue repair patches are utilized for vascular repair and gentle tissue healing. In recent years, the need for patches has increased due to the rising occurrence of atrial septal abnormalities and ventricular septal diseases. This has contributed to the expansion of the global market. The rapidly rising incidence of congenital cardiac problems, such as Atrial Septal Defect (ASD) and ventricular septal defect, is anticipated to boost demand for the patches. In addition, the increased use of patches in medical procedures and the prevalence of sports injuries are expected to contribute to the development and expansion of the market in the future years. According to studies, A.S.D. is the second most frequent type of congenital heart disease, with an incidence rate of 56 per 100,000 live births in the global population.

The rising prevalence of cardiovascular illnesses is among the most influential market forces. Changing lifestyles, rising obesity rates, adopting poor lifestyle choices, increasing alcohol consumption, smoking, and a growing senior population all contribute to the rise in heart problems. According to estimates from the World Health Organization, cardiovascular illnesses account for 32 percent or 17.9 million deaths annually. as per estimations by the Centers for Disease Control and Prevention, approximately 695,000 deaths in the United States are attributable to underlying heart disorders. Coronary heart illnesses account for the bulk of deaths caused by cardiac disorders. As per to the Centers for Disease Control and Prevention, coronary heart disorders were responsible for 360,900 fatalities in the United States.

To get more insights about this report Download Free Sample Report

Cardiovascular and Soft Tissue Repair Patches Market Growth Factors

Increasing Incidence of Cardiovascular Disease

The rapidly increasing incidence of congenital cardiac problems, such as Atrial Septal Defect (ASD) and ventricular septal defect, is anticipated to boost demand for the patches. In addition, the increased use of patches in medical procedures and the prevalence of sports injuries are expected to contribute to the development and expansion of the market in the future years. According to studies, A.S.D. is the second most frequent type of congenital heart disease, with an incidence rate of 56 per 100,000 live births in the global population. The rising prevalence of cardiovascular illnesses is among the most influential market forces. Changing lifestyles, rising obesity rates, adopting poor lifestyle choices, increasing alcohol consumption, smoking, and a growing senior population all contribute to the rise in heart problems. According to estimates from the World Health Organization, cardiovascular illnesses account for 32 percent or 17.9 million dyings yearly. As per the Centers for Disease Control and Prevention calculations, around 695,000 deaths in the United States are attributable to underlying heart disorders. Coronary heart illnesses account for the bulk of deaths caused by cardiac disorders.

Increasing Incidence of Hernias

The increasing prevalence of hernias, such as inguinal hernia, umbilical hernia, congenital diaphragmatic hernia, ventral hernia, and others, is another significant factor fueling expansion. Hernia risk factors include significant weight lifting, abdominal surgery, ascites, constipation, and persistent cough, which increase the pressure on the intra-abdominal regions, causing abdominal hernias. Inguinal hernias are the most prevalent abdominal hernias. The incidence rate of inguinal hernia rehabilitation in the United Kingdom is 10 per 100,000 people, whereas in the United States, it is 28 per 100,000 people. Due to hereditary causes and embryological channel abnormalities, the congenital diaphragmatic hernia develops. In treatments and wound care management, the causes above increase the patch market.

Restraining Factors

The Relative Scarcity of Supply and Immunogenic Potential

Included in this category are such considerations as a relatively limited supply and the potential for immunogenicity issues to arise from decellularized xenogenic tissue. Once implanted, the S.I.S. induced cell migration into itself and facilitated subsequent local tissue remodeling and regeneration in a study involving orthopedics. This was observed in a study that involved the field of orthopedics. This observation presents several intriguing questions. These discoveries hold a tremendous promise for future research into cardiac tissue regeneration.

Market Opportunities

Increasing Need for Patches in Heart and Soft Tissue Disease Diagnosis and Treatment

Research organizations, raw material suppliers, and essential manufacturers are collaborating to produce innovative solutions in response to the rising need for patches to diagnose and treat cardiac and soft tissue diseases. In addition, prominent players are concentrating on developing novel technologies comprised of tissue engineering materials, which is anticipated to stimulate the expansion of the market for cardiovascular and soft tissue repair patches. For instance, a research team from Tel Aviv University in Israel has created a bionic cardiac patch by integrating an organic living tissue with a nanoelectronic system; this device could be used to assist patients in healing from heart attacks. Increasing demand encourages public-private collaborations across many geographical markets, fostering development and expansion. For instance, governments are implementing steps to improve the affordability and accessibility of cardiac treatment alternatives, which is anticipated to stimulate economic growth. For example, the Japanese government supported and acknowledged the partnership between Osaka Medical College, Teijin Limited, and Fukui Warp Knitting Co., Ltd. to produce heart repair patches with regenerative properties. Governments are beginning to provide favorable assistance and encourage partnerships between medical and industrial players.

Regional Insights

North America dominated the cardiovascular and soft tissue repair patches market in 2021, accounting for 37.6% of total sales. This is due to fast-changing lifestyles, an expansion in the incidence of cardiovascular disease, an upsurge in the number of hernia problems, an increase in alcohol consumption and smoking, an increase in obesity levels, and an increase in substance abuse. According to estimates published in Annals of Laparoscopic and Endoscopic Surgery, 350,000 abdominal wall hernia repairs are conducted annually in the U.S. In North America, the market for cardiovascular and soft tissue repair patches is driven by an increase in disposable income, an improvement in healthcare infrastructure, the availability of novel products and technologies, and many important companies. In addition, the market in North America is driven by the rising joint efforts of raw material suppliers, pharmaceutical makers, and government agencies.

Asia-Pacific Cardiovascular and Soft Tissue Repair Patches Market Trends

On the other hand, Asia Pacific is expected to experience the highest growth rate over the next few years due to the rapid advancements in healthcare infrastructure, growing trends of minimally invasive surgical procedures, rising incidence of cardiac disease, growing medical tourism, rapid economic development in several countries such as China and India, a growing geriatric population, and an increasing burden of chronic disorders. Raising awareness of the importance of earlier diagnosis and detection of congenital heart problems, as well as implementing an immediate treatment plan, such as cardiac patch implantation, is driving the expansion. According to the World Health Organization, the yearly incidence rate of cardiovascular illnesses is projected to increase by 50 percent between 2022 and 2030, creating potential prospects for the Asia-Pacific market for cardiovascular and soft tissue repair patches.

Application Insights

In 2021, the soft tissue category dominated the cardiovascular and soft tissue repair patches market, accounting for 42.0% of total revenue. This is due to the rapidly increasing occurrence of hernias, such as ventral hernias, umbilical hernias, inguinal hernias, congenital diaphragmatic hernias, and others as the increasing demand for tissue repair patches in therapeutic operations. A growing frequency of inguinal hernia repairs is fueling the segment's rise. The International Surgery Journal estimated that around 28 per 100,000 patients in the United States underwent inguinal hernia procedures. In contrast, the cardiovascular and soft tissue repair market's cardiac repair segment is expected to develop at the fastest rate over the following years. This is due to the alarming increase in congenital heart disease among the world's pediatric population, which drives the demand for cardiac patches. According to studies, the atrial septal defect is the third most prevalent congenital heart disease, with a prevalence rate of 10% in pediatric congenital heart disease and 30% in adult congenital heart disease. To repair an atrial septal defect, two permanently linked cardiac patches are put in the hole to cover both the right and left atrial sides. In a few months, the gap closes entirely as the heart's inner lining develops over the area.

Raw Materials Insights

In 2021, the Eptfe category dominated the cardiovascular and soft tissue repair patches market, with a revenue share of 61.4 %. This segment expansion is attributable to the several advantages of ePTFE, including its high tensile strength, high durability, and easy accessibility. In addition, ePTFE is widely used in the production of medical accessories, including wound care materials, transducer protectors, ostomy bags, face masks, drainage bags, urine bags, and medical device enclosures. In contrast, the biomaterial and tissue-engineered material sector of the market for cardiovascular and soft tissue repair patches are predicted to expand at the fastest rate over the coming years. The increasingly popular bovine pericardium is the most common raw material in producing cardiovascular and soft tissue repair patches. Bovine pericardium possesses several physical and chemical features that enhance its use. In addition, bovine pericardium's benefits, such as its simple tolerance in the human body and reduced risk of post-operative problems, propel the market's expansion. The pericardium of bovines is constituted of a high proportion of structural proteins that provide greater suppleness and conformance to accommodate a variety of anatomical conditions. These patches are easily adaptable to certain combinations and dimensions. Additionally, these patches offer better convenience, dependability, and biocompatibility.

List of key players in Cardiovascular and Soft Tissue Repair Patches Market

1. Baxter
2. Admedus
3. Abbott
4. LeMaitre Vascular Inc.
5. Edwards Life Sciences Corporation
6. Glycar SA Pty Ltd.
7. LabCor
8. Cryolife Inc.
9. CorMatrix
10. Terumo Medical Corporation
11. Bard Peripheral Vascular Inc.
12. Neovasc
13. W.L. Gore & Associates Inc.
14. B.Braun
15. Novomedics
16. TEI Biosciences Inc.
17. Perouse Medical
18. Gunze Limited
19. Atriummed
20. Maverick Bioscience
21. Southern Lights Biomaterials.

To get more findings about this report Download Market Share

Recent Developments

• In April 2022, Baxter Highlights New Data at SCCM Critical Care Congress Showing Hemodynamic Monitoring May Help Predict Patient Outcomes.
• In July 2022, Abbott Receives FDA's Breakthrough Device Designation to Explore the Use of Deep Brain Stimulation to Manage Severe Depression.
• In June 2022, Easterseals and the Abbott Fund joined together to Advance Education and Health Equity.
• In March 2022, LeMaitre Joins NASDAQ Dividend Achievers Index – 10 Years of Dividend Increases.